Discover 1,283 paid clinical trials in Fort Collins, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,283
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Location: Denver CO, Albuquerque NM, Des Moines IA, Fargo ND,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT07022678
Phase 3, Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Denver CO, Aurora CO, Salt Lake City UT, Albuquerque NM,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 30
Code: NCT04546399
Phase 2, Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
for
Recurrent Langerhans Cell Histiocytosis,
Location: Denver CO, Aurora CO, Salt Lake City UT, Sioux Falls SD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 22
Code: NCT05828069
Phase 2, Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Denver CO, Aurora CO, Salt Lake City UT, Albuquerque NM,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT03959085
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
for
Embryonal Rhabdomyosarcoma,
Location: Denver CO, Aurora CO, Salt Lake City UT, Albuquerque NM,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT05304585
Phase 3, Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Location: Denver CO, Aurora CO, Salt Lake City UT, Albuquerque NM,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT04322318
Phase 2, Recruiting
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Project: Every Child for Younger Patients With Cancer
for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: Denver CO, Aurora CO, Salt Lake City UT, Albuquerque NM,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 25
Code: NCT02402244
Recruiting
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
for
Metastatic Malignant Neoplasm in the Lung,
Location: Denver CO, Aurora CO, Salt Lake City UT, Albuquerque NM,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT05235165
Phase 3, Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
for
Acute Myeloid Leukemia
Location: Denver CO, Aurora CO, Salt Lake City UT, Sioux Falls SD,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT04293562
Phase 3, Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
for
Hematopoietic and Lymphatic System Neoplasm,
Location: Denver CO, Aurora CO, Garden City KS, Great Bend KS,
Sponsor: Children's Oncology Group
Sex: Female
Age: 0 - 39
Code: NCT06513962
Phase 3, Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
for
Breast Neoplasms, Triple Negative Breast Neoplasms,
Location: Denver CO, Grand Junction CO, Murray UT, Yankton SD,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06966700
Phase 3, Recruiting
Project Dulce for Arab Americans With Type 2 Diabetes
for
Diabetes Mellitus, Type 2
Location: Denver CO
Sponsor: Scripps Whittier Diabetes Institute
Sex: All
Age: 18+
Code: NCT05580536
Recruiting
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
for
Breast Cancer
Location: Denver CO, Salt Lake City UT, Omaha NE, Henderson NV,
Sponsor: Greenwich LifeSciences, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05232916
Phase 3, Recruiting
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
for
Oligometastatic Prostate Cancer (OMPC)
Location: Denver CO, Omaha NE, Kansas City KS, Des Moines IA,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT05939414
Phase 3, Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
for
Metastatic HER2-positive Breast Cancer
Location: Denver CO, Aurora CO, Kansas City MO, Phoenix AZ,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06435429
Phase 3, Recruiting
Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
for
Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors,
Location: Denver CO, El Paso TX, San Antonio TX, Torrance CA,